Tag: health care

The Long (Un)Winding Road: FDA Maps Out How the End of the Public Health Emergency Will Impact its COVID-19 Policies ...

The 340B Drug Pricing Program is a government program, administered by the Health Resources and Services Administration (HRSA), that allows ...

The legislation previously introduced as the Pre-Approval Information Exchange Act of 2022 (“PIE Act”) was passed as part of Congress’s December 23, ...

On September 28, 2022, the U.S. Food and Drug Administration (“FDA” or “the Agency”) issued its long-awaited final guidance, “Clinical ...

FDA Announces Total Product Life Cycle Advisory Program (TAP) Pilot - Life Sciences Perspectives FDA Announces Total Product Life Cycle ...

Five Key Regulatory Considerations for Virtual Ketamine Clinics - Life Sciences Perspectives Five Key Regulatory Considerations for Virtual Ketamine Clinics ...

On July 28, 2022, the U.S. Food and Drug Administration (FDA) will hold a public advisory committee meeting to discuss ...

OIG Advisory Opinion Impacts Pharmaceutical & Medical Device Company Funding - Life Sciences Perspectives New OIG Advisory Opinion Impacts Pharmaceutical ...

Millions of women use reproductive health applications (or “apps”) to track menstrual cycles, ovulation, and pregnancy. These apps provide women ...

Significant Drug Pricing Reform Measures in the Inflation Reduction Act of 2022 - Life Sciences Perspectives Significant Drug Pricing Reform ...